Drug makers should learn to appreciate FDA needs better, say experts – Business Standard News
0
In the last one year, many of the Indian pharmaceutical majors have come under US FDA scanner and issued import alert – banning them from selling drugs in the US. After the strong warning issued against Wockhardt, others like Sun Pharma, IPCA Labs, Cadila have faced the wrath of FDA. However, the industry experts believe that the tough stance of FDA will improve the quality while Indian companies also need to adapt the culture change across the organisation.
Hitesh Sharma, National Leader – Life Sciences, Ernst & Young India said, “At the end of the day, regulators’ job is to verify the safety and quality of the drugs. Indian pharma industry has to go through these scrutinies as part of getting world class companies.”
Read more – Business Standard News